These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16799972)

  • 1. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.
    Lisman T; Bongers TN; Adelmeijer J; Janssen HL; de Maat MP; de Groot PG; Leebeek FW
    Hepatology; 2006 Jul; 44(1):53-61. PubMed ID: 16799972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.
    Palyu E; Harsfalvi J; Tornai T; Papp M; Udvardy M; Szekeres-Csiki K; Pataki L; Vanhoorelbeke K; Feys HB; Deckmyn H; Tornai I
    Thromb Haemost; 2018 Aug; 118(8):1397-1408. PubMed ID: 29972862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
    d'Alessio PA; Castaman G; Rodeghiero F; de Boer HC; Federici AB; Mannucci PM; de Groot PG; Sixma JJ; Zwaginga JJ
    Thromb Res; 1992 Jan; 65(2):221-8. PubMed ID: 1579897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
    Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
    Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.
    Stockschlaeder M; Schneppenheim R; Budde U
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):206-16. PubMed ID: 24448155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation.
    Pereboom IT; Adelmeijer J; van Leeuwen Y; Hendriks HG; Porte RJ; Lisman T
    Am J Transplant; 2009 May; 9(5):1189-96. PubMed ID: 19422343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13.
    Hugenholtz GC; Ruitenbeek K; Adelmeijer J; Pereboom IT; Meijers JC; van der Bij W; Porte RJ; Erasmus ME; Lisman T
    Am J Transplant; 2015 Jul; 15(7):1958-66. PubMed ID: 25846964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand Factor-GP1bα Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Hasan S; Abuelkasem E; Meyer M; Deatrick K; Taylor B; Kon Z; Herr D; Tanaka K
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2125-2132. PubMed ID: 30595484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
    PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.
    Reuken PA; Kussmann A; Kiehntopf M; Budde U; Stallmach A; Claus RA; Bruns T
    Liver Int; 2015 Jan; 35(1):37-45. PubMed ID: 25113276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood.
    Zwaginga JJ; Ijsseldijk MJ; Beeser-Visser N; de Groot PG; Vos J; Sixma JJ
    Blood; 1990 Apr; 75(7):1498-508. PubMed ID: 2156581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis.
    Federici AB; Berkowitz SD; Lattuada A; Mannucci PM
    Blood; 1993 Feb; 81(3):720-5. PubMed ID: 8427964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions.
    Moroi M; Jung SM; Nomura S; Sekiguchi S; Ordinas A; Diaz-Ricart M
    Blood; 1997 Dec; 90(11):4413-24. PubMed ID: 9373252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-dried plasma deficient in high-molecular-weight multimers of von Willebrand factor retains hemostatic properties.
    Meledeo MA; Liu QP; Peltier GC; Carney RC; McIntosh CS; Taylor AS; Bynum JA; Pusateri AE; Cap AP
    Transfusion; 2019 Feb; 59(2):714-722. PubMed ID: 30450617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.